
Holo, a Barcelona-based healthtech startup, has successfully secured €1 million in a pre-seed funding round to develop its AI-powered preventive health platform.
Founded by a trio of former employees of fellow Barcelona-based unicorn Factorial, Holo was built to redefine how consumers monitor and manage their health by offering a comprehensive, technology-driven approach to preventive care.
This innovative platform combines advanced biomarker testing, wearable integration, and personalized health insights to give users unprecedented control over their well-being. As such, individuals can monitor over 110 health indicators ranging from inflammation markers to hormonal balance, with insights delivered in user-friendly reports and reviewed by preventive medicine specialists.
With this new funding, Holo will be expanding its product features, partnership network, and geographic footprint, positioning itself as a key player in Europe’s evolving healthtech landscape.
“Health should be something we understand – not something we go blindly into until something goes wrong,” Francesc Navarro, CEO and co-founder of Holo, adding that the aim is to “build the Revolut of Health.”
“At Holo, we want everyone to have control over their well-being as easily as they track their finances,” Navarro continued.
Holo’s mantra of “being the Revolut of Health” means creating an intuitive, user-friendly ecosystem where users managing their health mirrors or closely feels like the seamlessness and easy-to-understand features people associate with fintech apps.
The €1 million funding round was led by Calm/Storm Venture and Spain’s Mission VC, with backing from from ENISA and a group of renowned business angels that includes Javier López and Emilio Nicolás (Magnific AI, Freepik), Carlos Villanueva (Google), Álex Rodríguez (MarsBased), Álvaro López (Polygon Labs), Samuel Fernández and Sergi Molins (Factorial), José de Cabo (Olapic, Remotely Works), Esteve Almirall (Node Living), and Luis Sanz (Carto).
This funding will primarily support product development, further integration with labs and health providers, and expansion beyond Spain’s borders, as Holo aims to capture the growing demand for preventive health solutions across Europe.
With plans to expand regionally starting in 2026, Holo is positioning itself as a major player in helping European populations better manage aging and chronic disease risks.
Because the startup’s tech offerings will utilize the fertile market of the growing wearable health tech market as well as the recent change in attitudes towards healthcare, it is able to provide a unified ecosystem that is capable of empowering users to better understand and act on their health data.
For instance, tests will be facilitated through partnerships with independent laboratories, which helps with avoiding the complexity of operating a medical service but maintaining clinical-grade quality.
Additionally, the Barcelona-based startup’s accessible pricing model and ability to combine clinical insights with real-time digital monitoring is a step forward in making preventive healthcare mainstream.
As Europe’s population ages and digital adoption becomes the order of the day, startups like Holo may shape the future of healthcare, country by country, by making their tech offerings more predictive, personalized, and consumer-centric.
